Category: BioAtla
-
BioAtla reports promising data in cancer drug trials By Investing.com
•
BioAtla, a biotechnology company, has announced its first-quarter financial results and provided a business update, highlighting positive data from ongoing clinical trials and the potential for strategic partnerships. The company showcased encouraging results from its CAB-ROR2-ADC drug in treating head and neck cancer and is preparing for FDA guidance on…